Caspase-6 (CASP6) is an enzyme encoded by the CASP6 gene in humans. It is a neuron degeneration-related protease and considered to be a potential drug-design target against neurodegenerative diseases.
Specificity
The antibody reacts specifically with procaspase 6 (Mch2).
Immunogen
synthetic peptide corresponding to the human N-terminal of procaspase 6α isoform (amino acids 27-44 with C-terminal added cysteine), conjugated to BSA. This sequence corresponds to the N-terminal of the human enzyme p18 subunit.
Application
Anti-Caspase 6 antibody produced in rabbit is suitable for microarray and western blotting at a dilution of 1:1,000 using Jurkat human T-cell leukemia cell extract.
Biochem/physiol Actions
Caspase-6 is strongly activated in Alzheimer disease brains and Huntington′s disease. It is important in most tissues during early development and is less involved in adult tissues. The low levels of Caspase-6 in fetal and adult brain indicate increased expression in Alzheimer Disease while the high levels of Caspase-6 in the gastrointestinal system indicate specific function of Caspase-6 in this tissues. It is a cysteinyl protease inducing axonal degeneration and is activated early in Alzheimer Disease (AD) brains. Casp6 is associated with the risk of developing AD in aged individuals.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 1% BSA and 15 mM sodium azide
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Caspase 6 (CASP6) is a neuron degeneration-related protease and is widely considered to be a potential drug-design target against neurodegenerative diseases such as Huntington's disease and Alzheimer's disease. The N-terminal pro-peptide of CASP6, also referred to as the pro-domain, contains
The Journal of biological chemistry, 287(43), 36000-36011 (2012-08-15)
Zinc and caspase-6 have independently been implicated in several neurodegenerative disorders. Depletion of zinc intracellularly leads to apoptosis by an unknown mechanism. Zinc inhibits cysteine proteases, including the apoptotic caspases, leading to the hypothesis that zinc-mediated inhibition of caspase-6 might
Neurobiology of aging, 34(7), 1815-1824 (2013-02-14)
Caspase-6 (Casp6), a cysteinyl protease that induces axonal degeneration, is activated early in Alzheimer Disease (AD) brains. To determine whether Casp6 activation is responsible for early cognitive impairment, we investigated the abundance of Casp6 activity, paired helical filament-1 (PHF-1) phosphorylated
Caspase-6 is an effector caspase that has not been investigated thoroughly despite the fact that Caspase-6 is strongly activated in Alzheimer disease brains. To understand the full physiological impact of Caspase-6 in humans, we investigated Caspase-6 expression. We performed western
A novel antibody-based protein microarray was developed that simultaneously determines expression of 31 stress-associated proteins in skin samples collected from free-ranging grizzly bears (Ursus arctos) in Alberta, Canada. The microarray determines proteins belonging to four broad functional categories associated with
Questions
Reviews
★★★★★ No rating value
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.